SEC 13F Intelligence

Rpo LLC / HQL

Rpo LLC’s Abrdn Life Sciences Investor Position

Does Rpo LLC own Abrdn Life Sciences Investor (HQL)? Not currently — the last reported position was 259.3K shares worth $4M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q2 2024
Shares
259.3K
% of Portfolio
+2.98%
Quarters Held
5
position exited

Position History HQL

Reported value by quarter
Q2 ’23: $3MQ2 ’23Q3 ’23: $4MQ3 ’23Q4 ’23: $5MQ4 ’23Q1 ’24: $5MQ1 ’24Q2 ’24: $4MQ2 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2024259.3K$4M+2.98%
Q1 2024338.5K$5M+6.63%
Q4 2023338.5K$5M+6.72%
Q3 2023327.0K$4M+4.60%
Q2 2023186.1K$3M+2.51%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rpo LLC’s full portfolio or all institutional holders of HQL.